Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAT first-line antihypertensive comparison in Tibetan patients with mild to moderate hypertension
ChiCTR-IPR-17012046Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) comparing Olmesartan sequence, Amlodipine sequence and Hydrochlorothiazide sequence (3 arms). Primary endpoint: blood pressure. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
olmesartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-IPR-17012046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012046.